Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis expressed transcript, Y-linked 18 (TTTY18) is a long noncoding RNA (lncRNA) located on the Y chromosome (Yp11.2), first annotated based on its expression in the testis, though its functional roles extend to other biological contexts[5][7]. It does not encode a protein but participates in the regulation of gene expression, especially in the context of environmental stress responses and cancer biology. Elevated TTTY18 expression is observed in certain cancers, particularly colorectal cancer, where it appears related to tumor progression marker profiles. Its expression is responsive to environmental pollutants and downregulated by anti-cancer phytochemicals like genistein. The mechanistic details of TTTY18 function are not fully established, and it is not currently classified as a druggable therapeutic target[5][1][3][7].
Downregulation of TTTY18 by genistein is associated with reduced cell viability and migration in cancer cells, and reduced tumor marker expression, suggesting TTTY18 may be involved in oncogenic pathways affected by genistein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis expressed transcript, Y-linked 18 (TTTY18).